A Molecular Signature of Radiosensitivity (RSI) is an RT-specific Biomarker in Prostate Cancer.

Saved in:
Bibliographic Details
Title: A Molecular Signature of Radiosensitivity (RSI) is an RT-specific Biomarker in Prostate Cancer.
Authors: Torres-Roca, J.F.1, Erho, N.2, Vergara, I.2, Davicioni, E.2, Jenkins, R.B.3, Den, R.B.4, Dicker, A.P.5, Eschrich, S.A.1
Source: International Journal of Radiation Oncology, Biology, Physics. Sep2014 Supplement, Vol. 90 Issue 1, pS157-S157. 1p.
Subjects: Prostate cancer treatment, Tumor markers, Radiation-sensitizing agents, Cancer radiotherapy, Molecular biology, Prostate cancer patients
Database: Engineering Source
Description
ISSN:03603016
DOI:10.1016/j.ijrobp.2014.05.642